Key result
Higher estimated pulse wave velocity is linked to ~55% higher all-cause mortality in refractory hypertension.
Why the study?
While arterial stiffness is a recognized driver of refractory hypertension, the clinical utility of estimated pulse wave velocity (ePWV) for prognostic risk stratification and mortality prediction in this population remained unclear.
Does baseline estimated pulse wave velocity (ePWV) predict all-cause and cardiovascular disease mortality in adult patients with refractory hypertension?
Cohort (n=943)
Does baseline estimated pulse wave velocity (ePWV) predict all-cause and cardiovascular disease mortality in adult patients with refractory hypertension?
Elevated estimated pulse wave velocity (ePWV) is independently associated with higher all-cause and cardiovascular mortality in patients with refractory hypertension, with cut-offs of 12.10 m/s and 13.78 m/s providing non-invasive thresholds for risk stratification.
Answers are grounded in this paper and cite their sources.
ePWV may refine mortality risk stratification in refractory hypertension; hypothesis-generating and requires prospective validation before clinical adoption.
Background Refractory hypertension (RH) carries a disproportionately high risk of cardiovascular disease (CVD) and target organ damage. While arterial stiffness is a recognized driver of RH, the clinical utility of estimated pulse wave velocity (ePWV) for prognostic risk stratification in this specific population remains unclear. Purpose To evaluate the independent association between ePWV, a surrogate marker of arterial stiffness, and mortality risks, aiming to establish reliable prognostic cut-offs for patients with RH. Methods This prospective cohort study analysed 943 adult patients with RH from the National Health and Nutrition Examination Survey (NHANES) 1999-2020. Participants were stratified into quartiles based on baseline ePWV. Multivariable Cox proportional hazards models were utilized to assess the relationship between ePWV and both all-cause and CVD mortality. The MaxStat method was applied to identify optimal prognostic cut-off values, followed by Kaplan-Meier survival analysis Results Among 943 patients with RH (45.07% male), significant baseline differences were observed across ePWV quartiles regarding age, race, and renal function (all P<0.05). In the fully adjusted model (Model 4), ePWV as a continuous variable was an independent risk factor for both all-cause mortality (hazard ratio [HR] 1.55, 95% CI: 1.31-1.83, P<0.001) and CVD mortality (HR 1.45, 95% CI: 1.09-1.93, P=0.011). Compared to the lowest quartile (Q1), patients in the highest quartile (Q4: 13.3-16.7 m/s) exhibited a dramatically increased risk of all-cause mortality (HR 6.41, 95% CI: 2.30-17.85, P<0.001). MaxStat identified optimal predictive cut-offs of 12.10 m/s for all-cause mortality and 13.78 m/s for CVD mortality (Figure 1). Subsequent Kaplan-Meier analysis confirmed that patients exceeding these respective ePWV thresholds experienced significantly higher cumulative mortality rates (Figure 2). Conclusion Elevated ePWV is independently associated with increased all-cause and CVD mortality in patients with RH. Utilizing ePWV cut-offs of 12.10 m/s and 13.78 m/s provides a robust, non-invasive method for early mortality risk stratification, offering valuable guidance for intensive clinical management in high-risk RH patients.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2026) conducted a cohort in Refractory hypertension (n=943). Estimated pulse wave velocity (ePWV) vs. Lowest ePWV quartile (Q1) or lower continuous ePWV was evaluated on All-cause mortality (HR 1.55, 95% CI 1.31-1.83, p=<0.001). Higher estimated pulse wave velocity independently increased all-cause and cardiovascular mortality in refractory hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: